Cyclodextrin-in-Liposome for therapy: Advances and challenges
The concept of drug-in-cyclodextrin-in-liposomes (DCLs) was introduced to the scientific community thirty years ago by McCormack and Gregoriadis (1994). Since
A forum for researchers, students and applicants in the field of cyclodextrin technology
The concept of drug-in-cyclodextrin-in-liposomes (DCLs) was introduced to the scientific community thirty years ago by McCormack and Gregoriadis (1994). Since
In this review the structural characteristics and complexation mechanisms of various flavonoid-cyclodextrin complexes were summarized and their influence on biological
Aspirin, a non-steroidal anti-inflammatory drug (NSAID), has garnered significant attention for its anti-cancer potential. This review [1] explores the pharmacological
This Special Issue in Pharmaceuticals intends to host research and review papers on the development of novel cyclodextrin-based drug delivery
Anti-cancer drugs are mostly limited in their use due to poor physicochemical and biopharmaceutical properties. Their lower solubility is the
The increase of payload is one of the key tasks in creation of nanocontainers for the delivery of bioactive substances
Drug carriers are special tools used for the transportation and preservation of molecules for several pharmaceutical, cosmetic and nutraceutical applications.
After a recent review on applicatipon of CD-based systems in cancer therapy a new review has been published by Kushik’s
Biohybrid bacteria–based microrobots are increasingly recognized as promising externally controllable vehicles for targeted cancer therapy. A range of bacteria, shown
In this work, it is demonstrated that liposome active motion takes advantage of mainly a pair of intrinsic material properties